Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Zamagni

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|December 16, 2020
The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple MyelomaE Zamagni, P Tacchetti, P Deias, et al.
Annali Di Chimica|February 24, 2001
Methodological approach for an integrated environmental monitoring system relative to heavy metals from an incineration plantL Morselli, F Passarini, E Zamagni, et al.
Expert Review of Hematology|July 14, 2016
Multiple myeloma: disease response assessmentE Zamagni, P Tacchetti, C Terragna, et al.
Seminars in Oncology|October 19, 2013
Role of consolidation therapy in transplant eligible multiple myeloma patientsMichele Cavo, Annamaria Brioli, P Tacchetti, et al.
Leukemia|July 29, 2000
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failureP Tosi, E Zamagni, S Ronconi, et al.
European Journal of Haematology|March 25, 1999
In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cellsP Tosi, A Pellacani, G Visani, et al.
European Journal of Radiology|August 28, 2012
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the diseaseP Spinnato, A Bazzocchi, A Brioli, et al.
European Journal of Haematology|August 1, 1997
Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M Bendandi, M Magagnoli, et al.
Haematologica|April 28, 2001
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantationP Tosi, S Ronconi, E Zamagni, et al.
Computational and Structural Biotechnology Journal|July 27, 2022
<b></b> : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors' profilesG Mazzocchetti, A Poletti, V Solli, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|December 16, 2020
The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple MyelomaE Zamagni, P Tacchetti, P Deias, et al.
Annali Di Chimica|February 24, 2001
Methodological approach for an integrated environmental monitoring system relative to heavy metals from an incineration plantL Morselli, F Passarini, E Zamagni, et al.
Expert Review of Hematology|July 14, 2016
Multiple myeloma: disease response assessmentE Zamagni, P Tacchetti, C Terragna, et al.
Seminars in Oncology|October 19, 2013
Role of consolidation therapy in transplant eligible multiple myeloma patientsMichele Cavo, Annamaria Brioli, P Tacchetti, et al.
Leukemia|July 29, 2000
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failureP Tosi, E Zamagni, S Ronconi, et al.
European Journal of Haematology|March 25, 1999
In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cellsP Tosi, A Pellacani, G Visani, et al.
European Journal of Radiology|August 28, 2012
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the diseaseP Spinnato, A Bazzocchi, A Brioli, et al.
European Journal of Haematology|August 1, 1997
Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M Bendandi, M Magagnoli, et al.
Haematologica|April 28, 2001
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantationP Tosi, S Ronconi, E Zamagni, et al.
Computational and Structural Biotechnology Journal|July 27, 2022
<b></b> : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors' profilesG Mazzocchetti, A Poletti, V Solli, et al.
Pageof 4